PubMed

Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.

Alvarsson M, Sundkvist G, Lager I, Henricsson M, Berntorp K, Fernqvist-Forbes E, Steen L, Westermark G, Westermark P, Orn T, Grill V.

Diabetes Care. 2003 Aug;26(8):2231-7.PMID: 12882841 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up.

Alvarsson M, Sundkvist G, Lager I, Berntorp K, Fernqvist-Forbes E, Steen L, Orn T, Holberg MA, Kirksaether N, Grill V.

Diabetes Obes Metab. 2008 May;10(5):421-9. Epub 2007 Mar 29.PMID: 17394534 [PubMed - indexed for MEDLINE]Related articles

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study.

Hanefeld M, Pfützner A, Forst T, Lübben G.

Curr Med Res Opin. 2006 Jun;22(6):1211-5.PMID: 16846554 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.

Raz I, Stranks S, Filipczak R, Joshi P, Lertoft B, Rastam J, Chow CC, Shaban J.

Clin Ther. 2005 Sep;27(9):1432-43.PMID: 16291416 [PubMed - indexed for MEDLINE]Related articles

Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up.

Clauson P, Karlander S, Steen L, Efendic S.

Diabet Med. 1996 May;13(5):471-7.PMID: 8737030 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.

Herz M, Sun B, Milicevic Z, Erickson P, Fövènyi J, Grzywa M, Pelikanova T.

Clin Ther. 2002 Jan;24(1):73-86.PMID: 11833837 [PubMed - indexed for MEDLINE]Related articles

Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.PMID: 11822582 [PubMed - indexed for MEDLINE]Related articles

Effects of two different glibenclamide dose-strengths in the fixed combination with metformin in patients with poorly controlled T2DM: a double blind, prospective, randomised, cross-over clinical trial.

Brunetti P, Pagano G, Turco C, Gori M, Perriello G; Glibo 5 Study Group.

Diabetes Nutr Metab. 2004 Dec;17(6):350-7.PMID: 15887629 [PubMed - indexed for MEDLINE]Related articles

Comparison of different insulin regimens in elderly patients with NIDDM.

Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC.

Diabetes Care. 1996 Dec;19(12):1326-32.PMID: 8941458 [PubMed - indexed for MEDLINE]Related articles

Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.

Osei K, O'Dorisio TM, Falko JM.

Am J Med. 1984 Dec;77(6):1002-9.PMID: 6439036 [PubMed - indexed for MEDLINE]Related articles

A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatment.

Kärvestedt L, Andersson G, Efendic S, Grill V.

J Intern Med. 2002 Apr;251(4):307-16.PMID: 11952881 [PubMed - indexed for MEDLINE]Related articles

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR; NN2211-1310 International Study Group.

Diabetes Care. 2004 Jun;27(6):1335-42.PMID: 15161785 [PubMed - indexed for MEDLINE]Related articlesFree article

Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.

Abbink EJ, van der Wal PS, Sweep CG, Smits P, Tack CJ.

Diabetes Metab Res Rev. 2004 Nov-Dec;20(6):466-71.PMID: 15386823 [PubMed - indexed for MEDLINE]Related articles

A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes.

Go EH, Kyriakidou-Himonas M, Berelowitz M.

Diabetes Metab Res Rev. 2004 May-Jun;20(3):225-31.PMID: 15133754 [PubMed - indexed for MEDLINE]Related articles

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.

Landstedt-Hallin L, Arner P, Lins PE, Bolinder J, Olsen H, Groop L.

Diabet Med. 1999 Oct;16(10):827-34.PMID: 10547209 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles